Antipsychotic-like Effects of Jobelyn® in Ketamine-induced Psychosis in Mice
Emerging Frontiers in Translational Biomedicine and Health Sciences · 2026-07-10 · 2 (1)
DOI: 10.66779/wt95rp14 ↗At a glance
Journal article in Emerging Frontiers in Translational Biomedicine and Health Sciences, published online on 2026-07-10. Written by Adrian Itivere Omogbiya and 9 co-authors. 46 references. The full text is freely available (open access, CC BY-NC-SA 4.0).
Abstract (original language)
Background
Jobelyn® (JB) is a polyherbal formulation with proven benefits on psychosis, a psychiatric disorder, validated in dopamine-agonist models. However, its effect in ketamine, a glutamate antagonist, is linked to schizophrenia's pathology due to N-methyl-D-aspartate (NMDA) receptor hypofunction, which remains largely unknown. Hence, this study investigates the antipsychotic effectsof JB in ketamine-induced mouse models.
Methods
Antipsychotic activity of Jobelyn®(JB) (5, 10, and 50 mg/kg, p.o.) was assessed based on the inhibition of stereotyped behaviour induced by ketamine and ketamine-induced hyperactivity in mice. Ketamine-enhanced immobility in forced swim test (FST) and drug-induced ptosis and catalepsy in mice were also used to further evaluate JB's antipsychotic properties and its potential to cause extrapyramidal side effects.
Results
JB (5, 10, and 50 mg/kg, p.o.) significantly (p
Cite
APA
Omogbiya, A. I., Ben-Azu, B., Oboh, M., Jewo, A. O., Orovwigho, O., Oritsemuelebi, B., Okoro, E. O., Bamitale, P. E., Kemelayefa, J. O., & Awhin, E. P. (2026). Antipsychotic-like Effects of Jobelyn® in Ketamine-induced Psychosis in Mice. Emerging Frontiers in Translational Biomedicine and Health Sciences, 2(1). https://doi.org/10.66779/wt95rp14
Vancouver
Omogbiya AI, Ben-Azu B, Oboh M, Jewo AO, Orovwigho O, Oritsemuelebi B, et al. Antipsychotic-like Effects of Jobelyn® in Ketamine-induced Psychosis in Mice. Emerging Frontiers in Translational Biomedicine and Health Sciences. 2026;2(1). doi:10.66779/wt95rp14
BibTeX
@article{Omogbiya2026,
author = {Omogbiya, Adrian Itivere and Ben-Azu, Benneth and Oboh, Maxwell and Jewo, Augustina Oghenevwaerhe and Orovwigho, Oruese and Oritsemuelebi, Benjamin and Okoro, Edith Omozefe and Bamitale, Priestley E. and Kemelayefa, James Ozakieoniso and Awhin, Ejiro Prosper},
title = {Antipsychotic-like Effects of Jobelyn® in Ketamine-induced Psychosis in Mice},
journal = {Emerging Frontiers in Translational Biomedicine and Health Sciences},
year = {2026},
volume = {2},
number = {1},
doi = {10.66779/wt95rp14}
}
EUVIMED